Regulation of plasma cholesterol esterification by sphingomyelin: Effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1821, Issue 6, 2012, Pages 908-913

  Subbaiah, Papasani Venkata ^a   Jiang, Xian Cheng ^b   Belikova, Natalia A ^a   Aizezi, Buzulagu ^a   Huang, Zhi Hua ^a   Reardon, Catherine A ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SUNY Downstate Medical Center   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apo E deficient mouse; Cholesteryl ester composition; LCAT activity; LDL receptor deficient mouse; Serine palmitoyl transferase deficiency; Sphingomyelin synthase 2 deficiency

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; LIVER ENZYME; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SERINE PALMITOYLTRANSFERASE; SPHINGOMYELIN; SYNTHETASE;

ANIMAL EXPERIMENT; ARTICLE; ATHEROGENESIS; BIOSYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME SUBSTRATE; ESTERIFICATION; GENETIC MODEL; IN VIVO STUDY; MOUSE; NONHUMAN; PHYSIOLOGY; PLASMA; PRIORITY JOURNAL;

ANIMALS; APOLIPOPROTEINS E; CHOLESTEROL; CHOLESTEROL ESTERS; ESTERIFICATION; LIPIDS; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHATIDYLCHOLINES; RECEPTORS, LDL; SERINE C-PALMITOYLTRANSFERASE; SPHINGOMYELINS; SUBSTRATE SPECIFICITY; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

MUS;

EID: 84859368750     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.02.007     Document Type: Article

References (47)

1. A. Jonas Lecithin cholesterol acyltransferase Biochim. Biophys. Acta 1529 2000 245 256
2. X. Rousset, B. Vaisman, M. Amar, A.A. Sethi, and A.T. Remaley Lecithin: cholesterol acyltransferase - from biochemistry to role in cardiovascular disease Curr. Opin. Endocrinol. Diabetes Obes. 16 2009
3. J.A. Glomset Lecithin: cholesterol acyltransferase. An exercise in comparative biology, Prog Biochem. Pharmacol. 15 1979 41 66
4. M. Dobiasova Lecithin: cholesterol acyltransferase and the regulation of endogenous cholesterol transport Adv. Lipid Res. 20 1983 107 194
5. X. Rousset, R. Shamburek, B. Vaisman, M. Amar, and A. Remaley Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor? Curr. Atheroscler. Rep. 13 2011 249 256
6. A.A. Sethi, M. Sampson, R. Warnick, N. Muniz, B. Vaisman, B.G. Nordestgaard, A. Tybjaerg-Hansen, and A.T. Remaley High pre-{beta}1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol Clin. Chem. 56 2010 1128 1137
7. L. Calabresi, and G. Franceschini Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans Trends Cardiovasc. Med. 20 2010 50 53
8. R.P.F. Dullaart, F. Perton, M.M. van der Klauw, H.L. Hillege, and W.J. Sluiter High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol Atherosclerosis 208 2010 537 542
9. A. Jonas Regulation of lecithin cholesterol acyltransferase activity Prog. Lipid Res. 37 1998 209 234 (Pubitemid 28421192)
10. P.V. Subbaiah, and M. Liu Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase J. Biol. Chem. 268 1993 20156 20163 (Pubitemid 23278915)
11. 2 in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin Biochemistry 41 2002 4911 4920 (Pubitemid 34298658)
12. 2 Arch. Biochem. Biophys. 459 2007 280 287 (Pubitemid 46389600)
13. 2 by sphingolipids J. Lipid Res. 48 2007 683 692 (Pubitemid 46397471)
14. D.J. Bolin, and A. Jonas Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding J. Biol. Chem. 271 1996 19152 19158 (Pubitemid 26271578)
15. K.A. Rye, N.J. Hime, and P.J. Barter The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins J. Biol. Chem. 271 1996 4243 4250
16. D.L. Sparks, P.G. Frank, and T.A.M. Neville Effect of the surface lipid composition of reconstituted LpA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity Biochim. Biophys. Acta 1390 1998 160 172 (Pubitemid 28122334)
17. R.G. Lee, K.L. Kelley, J.K. Sawyer, R.V. Farese Jr., J.S. Parks, and L.L. Rudel Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential Circ. Res. 95 2004 998 1004 (Pubitemid 39532330)
18. T.S. Jeong, S.L. Schissel, I. Tabas, H.J. Pownall, A.R. Tall, and X.C. Jiang Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase J. Clin. Invest. 101 1998 905 912 (Pubitemid 28096088)
19. Z. Li, H. Zhang, J. Liu, C.p. Liang, Y. Li, Y. Li, G. Teitelman, T. Beyer, H.H. Bui, D.A. Peake, Y. Zhang, P.E. Sanders, M.S. Kuo, T.S. Park, G. Cao, and X.C. Jiang Reducing plasma membrane sphingomyelin increases insulin sensitivity Mol. Cell. Biol. 31 2011 4205 4218
20. T.K. Hailemariam, C. Huan, J. Liu, Z. Li, C. Roman, M. Kalbfeisch, H.H. Bui, D.A. Peake, M.S. Kuo, G. Cao, R. Wadgaonkar, and X.C. Jiang Sphingomyelin synthase 2 deficiency attenuates NF{kappa}B activation Arterioscler. Thromb. Vasc. Biol. 28 2008 1519 1526
21. Y. Fan, F. Shi, J. Liu, J. Dong, H.H. Bui, D.A. Peake, M.S. Kuo, G. Cao, and X.C. Jiang Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 30 2010 2114 2120
22. M.R. Hojjati, Z. Li, and X.C. Jiang Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice Biochim. Biophys. Acta 1737 2005 44 51 (Pubitemid 41550382)
23. P.V. Subbaiah, M. Liu, and T.R. Witt Impaired cholesterol esterification in the plasma in patients with breast cancer Lipids 32 1997 157 162 (Pubitemid 27093187)
24. K.T. Stokke, and K.R. Norum Determination of lecithin:cholesterol acyltransferase in human blood plasma Scand. J. Clin. Lab. Invest. 27 1971 21 27
25. C.H. Chen, and J.J. Albers Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity J. Lipid Res. 23 1982 680 691 (Pubitemid 13227199)
26. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can. J. Biochem. Physiol. 37 1959 911 917
27. J. Liu, H. Zhang, Z. Li, T.K. Hailemariam, M. Chakraborty, K. Jiang, D. Qiu, H.H. Bui, D.A. Peake, M.S. Kuo, R. Wadgaonkar, G. Cao, and X.C. Jiang Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice Arterioscler. Thromb. Vasc. Biol. 29 2009 850 856
28. -/- mouse LDL in vitro predicts its atherogenic role in vivo Arterioscler. Thromb. Vasc. Biol. 29 2009 532 538
29. J.W. Furbee, O. Francone, and J.S. Parks In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice J. Lipid Res. 43 2002 428 437 (Pubitemid 34252273)
30. T.M. Forte, G. Subbanagounder, J.A. Berliner, P.J. Blanche, A.O. Clermont, Z. Jia, M.N. Oda, R.M. Krauss, and J.K. Bielicki Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice J. Lipid Res. 43 2002 477 485 (Pubitemid 34252278)
31. T. Seo, P.M. Oelkers, M.R. Giattina, T.S. Worgall, S.L. Sturley, and R.J. Deckelbaum Differential modulation of ACAT1 and ACAT2 transcription and activity by long chain free fatty acids in cultured cells Biochemistry 40 2001 4756 4762 (Pubitemid 32374663)
32. M. Liu, E.S. Krul, and P.V. Subbaiah Effect of apoprotein B conformation on the activation of lysolecithin acyltransferase and lecithin:cholesterol acyltransferase. Studies with subfractions of low density lipoproteins J. Biol. Chem. 267 1992 5139 5147
33. P.V. Subbaiah, and R.M. Sargis Sphingomyelin: a natural modulator of membrane homeostasis and inflammation Med. Hypotheses 57 2001 135 138 (Pubitemid 32681632)
34. L.I.B. Lobo, and D.C. Wilton Combined effects of sphingomyelin and cholesterol on the hydrolysis of emulsion particle triolein by lipoprotein lipase Biochim. Biophys. Acta 1349 1997 122 130 (Pubitemid 27519554)
35. U.C. Broedl, W. Jin, and D.J. Rader Endothelial lipase: a modulator of lipoprotein metabolism upregulated by inflammation Trends Cardiovasc. Med. 14 2004 202 206 (Pubitemid 38942829)
36. P.V. Subbaiah, P. Horvath, and S.B. Achar Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate Biochemistry 45 2006 5029 5038
37. Y. Zhao, F.E. Thorngate, K.H. Weisgraber, D.L. Williams, and J.S. Parks Apolipoprotein E is the major physiological activator of lecithin cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins Biochemistry 44 2004 1013 1025 (Pubitemid 40129661)
38. C.H. Chen, and J.J. Albers Activation of lecithin: cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma Biochim. Biophys. Acta 836 1985 279 285 (Pubitemid 15244141)
39. K.A. Rye, R. Bright, M. Psaltis, and P.J. Barter Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E J. Lipid Res. 47 2006 1025 1036 (Pubitemid 43764698)
40. J. Ma, A.R. Folsom, L. Lewis, and J.H. Eckfeldt Relation of plasma phospholipid and cholesterol ester fatty acid composition to carotid artery intima-media thickness: the Atherosclerosis Risk in Communities (ARIC) Study Am. J. Clin. Nutr. 65 1997 551 559 (Pubitemid 27130766)
41. M. Ohrvall, L. Berglund, I. Salminen, H. Lithell, A. Aro, and B. Vessby The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up Atherosclerosis 127 1996 65 71 (Pubitemid 26425843)
42. L. Swell, H. Field, and C.R. Treadwell Correlation of arachidonic acid of serum cholesterol esters in different species with susceptibility to atherosclerosis Proc. Soc. Exp. Biol. Med. 104 1960 325 328
43. W. Chen, and J. Li Correlation of serum cholesteryl ester fatty acids composition with susceptibility to atherosclerosis in different species Chin. J. Med. 106 1994 163 166
44. L.L. Rudel, J.S. Parks, and J.K. Sawyer Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African Green Monkeys from coronary artery atherosclerosis Arterioscler. Thromb. Vasc. Biol. 15 1995 2101 2110 (Pubitemid 26001412)
45. X.C. Jiang, F. Paultre, T.A. Pearson, R.G. Reed, C.K. Francis, M. Lin, L. Berglund, and A.R. Tall Plasma sphingomyelin level as a risk factor for coronary artery disease Arterioscler. Thromb. Vasc. Biol. 20 2000 2614 2618
46. T.S. Park, W. Rosebury, E.K. Kindt, M.C. Kowala, and R.L. Panek Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice Pharmacol. Res. 58 2008 45 51
47. A. Schlitt, S. Blankenberg, D. Yan, H. von Gizycki, M. Buerke, K. Werdan, C. Bickel, K.J. Lackner, J. Meyer, H.J. Rupprecht, and X.C. Jiang Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease Nutr. Metab. (Lond) 3 2006 5 13